Complete this form and receive a comprehensive mesothelioma & asbestos packet with detailed information about where to get treatment, legal options, how to cope, and much more.





Have you or a loved one been diagnosed with Mesothelioma, lung cancer or an asbestos-related disease?

Privacy Policy

Asbestos was used for decades in construction and shipbuilding. If you or someone close to you has worked as a drywaller, pipefitter, or in the Navy, you may have been exposed to harmful asbestos fibers. Learn more >

Mesothelioma is a deadly, elusive cancer caused by exposure to asbestos. We provide free resources to help you understand diagnosis, treatment, and more. Learn more >

Dealing with asbestos-related disease can be hard. Finding the right doctor or hospital can make all the difference. Click here to see how we can help. Learn more >

Mesothelioma doesn't have to tear your family apart. We help you and your family get through this difficult time together. Click here to learn more. Learn more >

New Drug Tested for Treatment of Mesothelioma

Research hospitals in Europe have successfully tested a new anticancer drug, “Vinflunine” (pronounced VIN-floo-neen). The October 20th issue of Journal of Clinical Oncology featured the news that Vinflunine has been shown to improve response and survival rates in patients diagnosed with malignant pleural mesothelioma, according to Reuters.

Mesothelioma is a rare, deadly form of cancer that affects the inside lining of the chest cavity and is directly associated with asbestos exposure.

Vinflunine was recently tested in Phase II clinical trials at hospital research centers in England and France. Dr. Talbot, from the Churchill Hospital in Oxford, and medical colleagues at seven European hospital centers, assessed the response rates of 67 patients who had not received prior chemotherapy or radiotherapy to determine the effectiveness of first-line Vinflunine treatment.

Doctors concluded that Vinflunine, when administered approximately every 21 days in high doses, improved patients’ response rates by 13.8 percent, and demonstrated such positive results that the drug therapy warrants further evaluation. In 2004, the Food and Drug Administration approved the first drug for this condition, “Alimta,” which, when used in combination with cisplatin, has helped patients extend their lives by several months, according to the FDA.

About 2,000 cases of mesothelioma are diagnosed in the United States every year, based on statistics from the National Cancer Institute. Current treatments are limited and usually include some form of surgery, combined with chemotherapy or radiation. The disease, which is often linked to industrial workplace exposure to asbestos, is usually contracted through employers’ disregard for health safety.

For more information, contact the Mesothelioma Lawyers at Williams Kherkher at 1.800.220.9341.

Leave a comment

Privacy Policy

Archives

Categories

Blogroll

home  |  asbestos  |  mesothelioma  |  treatment  |  legal options  |  veterans  |  clinical trials  |  press  |  helpful resources  |  contact us  |  articles  |  blog  |  about  |  locations  |  sitemap  |  Log in
Copyright © 2004-2011 This Website has been prepared solely for the purpose of providing information about Williams Kherkher Law Firm, L.L.P., and the services and products it offers. Click here for the full disclaimer. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-781-3955 | John Eddie Williams + | Find us on Google+